SCM
TELA icon

Silverarc Capital Management’s TELA Bio TELA Stock Holding History

Silverarc Capital Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Sell
2,259,312
-388,200
-15% -$337K 0.14% 63
2025
Q4 		$3.12M Sell
2,647,512
-135,411
-5% -$171K 0.43% 51
2025
Q3 		$4.15M Buy
2,782,923
+3,128
+0.1% +$5.51K 0.56% 47
2025
Q2 		$5.39M Buy
2,779,795
+8,507
+0.3% +$11.1K 0.99% 28
2025
Q1 		$3.38M Sell
2,771,288
-294,361
-10% -$724K 0.69% 38
2024
Q4 		$9.26M Buy
3,065,649
+1,940,721
+173% +$5.46M 2.03% 18
2024
Q3 		$2.85M Buy
1,124,928
+124,928
+12% +$444K 0.64% 44
2024
Q2 		$4.7M Buy
1,000,000
+223,149
+29% +$1.18M 1.11% 30
2024
Q1 		$4.4M Sell
776,851
-18,229
-2% -$120K 1.22% 28
2023
Q4 		$5.26M Buy
795,080
+304,609
+62% +$1.76M 1.57% 26
2023
Q3 		$3.92M Buy
490,471
+74,031
+18% +$688K 1.19% 36
2023
Q2 		$4.22M Buy
416,440
+362,344
+670% +$3.71M 1.3% 26
2023
Q1 		$576K Buy
+54,096
New +$597K 0.24% 64

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Silverarc Capital Management's TELA Position: Q1 2026 in Review

Silverarc Capital Management reduced its TELA Bio (TELA) stake by 15% in Q1 2026, selling an estimated $337K and leaving 2,259,312 shares worth $1.4M. The position accounts for 0.14% of the portfolio, ranked #63.

Silverarc Capital Management first reported a position in TELA in Q1 2023 and has held it in 13 quarters since. The position peaked at $9.26M in Q4 2024. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • Silverarc Capital Management held 2,259,312 shares of TELA Bio worth $1.4M as of Q1 2026.
  • Silverarc Capital Management sold 388,200 TELA Bio shares in Q1 2026, an estimated $337K.
  • TELA Bio made up 0.14% of Silverarc Capital Management's portfolio in Q1 2026, its #63 holding.
  • Silverarc Capital Management first reported a position in TELA Bio in Q1 2023 and has held it in 13 quarters since.
  • Silverarc Capital Management's TELA Bio position peaked at $9.26M in Q4 2024.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Silverarc Capital Management's 13F filing for Q1 2026, filed 14 May 2026.